These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11762944)

  • 21. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
    Dalkilic E; Alkis N; Kamali S
    Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of granulomatosis with polyangiitis (Wegener's).
    Pagnoux C; Guillevin L
    Expert Rev Clin Immunol; 2015 Mar; 11(3):339-48. PubMed ID: 25644677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
    Henes JC; Fritz J; Koch S; Klein R; Horger M; Risler T; Kanz L; Koetter I
    Clin Rheumatol; 2007 Oct; 26(10):1711-5. PubMed ID: 17502992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
    Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
    Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
    Benenson E; Fries JW; Heilig B; Pollok M; Rubbert A
    Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-cell depletion in Wegener's granulomatosis.
    Hinze CH; Colbert RA
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):372-9. PubMed ID: 18172780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
    Azar L; Springer J; Langford CA; Hoffman GS
    Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refractory antineutrophil cytoplasmic antibody-associated vasculitis successfully treated with rituximab: a case report.
    Horai Y; Miyamura T; Takahama S; Hirata A; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
    Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(2):105-10. PubMed ID: 20453447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
    Keogh KA; Wylam ME; Stone JH; Specks U
    Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
    Tektonidou MG; Skopouli FN
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S103. PubMed ID: 16859607
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment].
    Novikov PI; Krivosheev OG; Semenkova EN
    Ter Arkh; 2011; 83(11):70-6. PubMed ID: 22312891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood.
    Ferraro AJ; Smith SW; Neil D; Savage CO
    Nephrol Dial Transplant; 2008 Sep; 23(9):3030-2. PubMed ID: 18586761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients.
    Wendt M; Gunnarsson I; Bratt J; Bruchfeld A
    Scand J Rheumatol; 2012 Mar; 41(2):116-9. PubMed ID: 22118245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement.
    Roccatello D; Baldovino S; Alpa M; Rossi D; Napoli F; Naretto C; Cavallo R; Giachino O
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S67-71. PubMed ID: 18799057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract]   [Full Text] [Related]  

  • 40. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
    Geetha D; Specks U; Stone JH; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Fessler BJ; Ding L; Tchao NK; Ikle D; Jepson B; Brunetta P; Fervenza FC;
    J Am Soc Nephrol; 2015 Apr; 26(4):976-85. PubMed ID: 25381429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.